Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -62.98% is in line with its 5-year average of -62.56%, around the middle of its 5-year range (-128.20%–-34.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.39% above its 12-month average of -91.79%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -62.98%.
RETURN ON INVESTED CAPITAL (ROIC)
-62.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-91.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-72.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-62.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+31.39%
CURRENT VS 3Y AVG
+13.25%
CURRENT VS 5Y AVG
-0.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-76.70%
vs the sector median at left
Hyperfine, Inc.
Market Cap
$75.89M
Return on Invested Capital (ROIC)
-62.98%
TTM Avg
-91.79%
3Y Avg
-72.60%
5Y Avg
-62.56%
Market Cap
$75.82M
Return on Invested Capital (ROIC)
-48.39%
TTM Avg
-44.64%
3Y Avg
-40.56%
5Y Avg
-32.79%
Market Cap
$75.53M
Return on Invested Capital (ROIC)
-1.02%
TTM Avg
-7.84%
3Y Avg
-8.62%
5Y Avg
-7.82%
Market Cap
$76.76M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.15M
Return on Invested Capital (ROIC)
-59.79%
TTM Avg
-61.79%
3Y Avg
-56.24%
5Y Avg
-67.61%
Market Cap
$77.38M
Return on Invested Capital (ROIC)
-836.58%
TTM Avg
-213.85%
3Y Avg
-158.30%
5Y Avg
-121.35%
Market Cap
$77.76M
Return on Invested Capital (ROIC)
-33.27%
TTM Avg
-39.30%
3Y Avg
-47.63%
5Y Avg
-42.37%
Market Cap
$72.09M
Return on Invested Capital (ROIC)
-159.24%
TTM Avg
-170.07%
3Y Avg
-147.54%
5Y Avg
-112.39%
Market Cap
$79.41M
Return on Invested Capital (ROIC)
-11.48%
TTM Avg
-56.27%
3Y Avg
-1130.61%
5Y Avg
-797.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $75.89M | -62.98% | -91.79% | -72.60% | -62.56% |
| Pulmonx Corporation (LUNG)vs › | $75.82M | -48.39% | -44.64% | -40.56% | -32.79% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.53M | -1.02% | -7.84% | -8.62% | -7.82% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.76M | N/A | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | -59.79% | -61.79% | -56.24% | -67.61% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.38M | -836.58% | -213.85% | -158.30% | -121.35% |
| Outset Medical, Inc. (OM)vs › | $77.76M | -33.27% | -39.30% | -47.63% | -42.37% |
| Gain Therapeutics, Inc. (GANX)vs › | $72.09M | -159.24% | -170.07% | -147.54% | -112.39% |
| vTv Therapeutics Inc. (VTVT)vs › | $79.41M | -11.48% | -56.27% | -1130.61% | -797.97% |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.16M | -207.23% | -106.05% | -91.39% | -77.29% |
ROIC
-63.0%
ROE
-94.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -62.98% |
| 2026-03-31 | -69.23% |
| 2025-12-31 | -85.19% |
| 2025-09-30 | -128.20% |
| 2025-06-30 | -113.37% |
| 2025-03-31 | -95.77% |
| 2024-12-31 | -86.15% |
| 2024-09-30 | -74.19% |
| 2024-06-30 | -66.18% |
| 2024-03-31 | -59.64% |
| 2023-12-31 | -56.32% |
| 2023-09-30 | -52.83% |
| 2023-06-30 | -49.38% |
| 2023-03-31 | -55.34% |
| 2022-12-31 | -58.98% |
| 2022-09-30 | -63.54% |
| 2022-06-30 | -59.13% |
| 2022-03-31 | -48.28% |
| 2021-12-31 | -34.74% |
| 2021-09-30 | -67.56% |
| 2021-06-30 | -43.14% |
| 2021-03-31 | -12.39% |
| 2020-12-31 | -34.85% |
